| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |